Cerus Corp. appointed Eric Bjerkholt as a director.
Bjerkholt is the CFO of Aimmune Therapeutics Inc., which develops treatments for people with food allergies. He is also a board member at Corium International Inc.
Concord, Calif.-based Cerus develops biomedical products, with a focus on blood transfusion safety.